跳至主要内容
临床试验/EUCTR2004-000446-20-IE
EUCTR2004-000446-20-IE进行中(未招募)不适用

A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection - SPARTAC

Imperial College0 个研究点目标入组 360 人开始时间: 2006年6月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Have reached the age of consent in their country for participating in a clinical study
  • 2. Are confirmed primary HIV infection by at least one of the following criteria:
  • - HIV positive antibody test within 6 months of an HIV negative antibody test
  • - HIV antibody negative with positive RT-PCR test
  • - Test incident at low level (<0.6) using detuned assay (must be subtype B)
  • - Equivocal HIV antibody test supported by a repeat test within a 2 week period showing a rising optical density
  • - Have clinical manifestations of symptomatic HIV seroconversion illness supported by antigen positivity and <4 bands on Western Blot
  • 3. Are able and willing to give written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Pregnant
  • 2. Unlikely to comply with protocol, and in particular adhere to therapeutic regimen
  • 3. Likely to use narcotics during the study period
  • 4. Antiretroviral therapy is indicated
  • 5. Antiretroviral therapy is contraindicated

研究者

发起方
Imperial College

相似试验